Updated on 7 January 2014
"We're applying a bit of American-style transitioning. Michael Thomas did a phenomenal job of really taking a high technology concept to a product ready to sell," he said.
The company has developed a device that monitors wheezing in asthmatics, which occurs when airways are constricted. The device keeps a journal in the cloud, which can be downloaded at the next visit to the doctor.
The company sells its devices online in Australia for $160. The product is approved in Europe, while in the US iSonea's device can be sold with a prescription. The outcome of an application for over-the-counter sales is expected midyear.
Outgoing chairman Dr Washer said he had reached the limit of his most useful skills. "My sweet spot is taking technologies from a good, solid concept to a good product and well on their way to a good, stable business," he said.